Deltec Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Deltec Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-106,410	Closed	-$549K	–	189
2019 Q2	$549K	Buy	+106,410	New	+$478K	0.12%	118

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Deltec Asset Management's PETX Position: Q3 2019 in Review

Deltec Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 106,410 shares — an estimated $549K sold.

Deltec Asset Management first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $549K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Deltec Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Deltec Asset Management sold 106,410 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $549K.
Deltec Asset Management first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Deltec Asset Management's Aratana Therapeutics, Inc. position peaked at $549K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Deltec Asset Management's 13F filing for Q3 2019, filed 24 Oct 2019.